Publication | Closed Access

Clinical utility of newly developed immunoassays for serum concentrations of adalimumab and anti-adalimumab antibodies in patients with Crohn’s disease

InflammationAnti-adalimumab AntibodiesAutoimmune DiseaseAllergyClinical UtilityImmunologyGastroenterologyInflammatory MarkerAutoimmunityInflammatory Rheumatic DiseaseImmune-mediated Inflammatory DiseasesUlcerative ColitisSerum ConcentrationsMedicine